Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex

Fig. 2

Comparison of the scale scores on the Medical Outcomes Study 36-Item Short Form 3 months after the initiation of sirolimus gel treatment for facial angiofibroma associated with tuberous sclerosis complex between patients with and without improved facial angiofibroma. PF, physical function; RP, role limitations because of physical health problems; BP, bodily pain; GH, general health perception; VT, vitality; SF, social function; RE, role limitations because of emotional problems; MH, mental health. *, P < 0.05. The scale scores of the VT and SF in patients whose FA had improved were significantly higher than those whose condition did not improve

Back to article page